Does TACROLIMUS Cause Transplant rejection? 3,526 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,526 reports of Transplant rejection have been filed in association with TACROLIMUS (Tacrolimus). This represents 3.9% of all adverse event reports for TACROLIMUS.
3,526
Reports of Transplant rejection with TACROLIMUS
3.9%
of all TACROLIMUS reports
352
Deaths
1,135
Hospitalizations
How Dangerous Is Transplant rejection From TACROLIMUS?
Of the 3,526 reports, 352 (10.0%) resulted in death, 1,135 (32.2%) required hospitalization, and 311 (8.8%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 3,526 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
Death (2,762)
What Other Drugs Cause Transplant rejection?
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
INFLIXIMAB (432)
Which TACROLIMUS Alternatives Have Lower Transplant rejection Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB